Surprisingly, while Ryan MC et al. [33] reported that only 2% of breast cancer patients were positive for CD70 (N = 204) while using a cut-off of 1%, our study showed that 47.6% breast cancer patients were CD70 positive (cut-off of 10%). The gene discussed is CD70; the disease is breast cancer.